Prime-Boost Vaccine Study Shows Modest Effect in Preventing HIV

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Global Solutions for Infectious Diseases (“GSID”) announced today that a Phase III clinical trial of an investigational HIV vaccine regimen has been shown to be safe and modestly effective in preventing HIV infection. The double-blind, placebo controlled study was conducted in Thailand among more than 16,000 volunteers. The clinical trial (RV 144), the world’s largest study of an HIV/AIDS vaccine regimen, demonstrated that the combi

For more information, please visit
http://www.businesswire.com/news/home/20090924005221/en

You need to login to post comments.

Feed last updated 1969/12/31 @7:00 PM

0 COMMENTS:

VOCAPIA and SYSTRAN demonstrate an automated speech translation solution at EUROSATORY 2016 - GlobeNewswire (press release) views: 1536

Instagram is adding automatic in-app text translation - The Verge views: 1524

Here’s a ‘Brand-New’ Massive Multilingual Dataset for Machine Translation views: 1518

F.A.Q. | Terms and conditions